Menu Fermer

Articles sur COVID-19

Affichage de 2921 à 2940 de 7945 articles

The AstraZeneca vaccine was 70 per cent effective against symptomatic COVID-19 infection in a large multinational study, and recently reported 76 per cent overall efficacy against symptomatic COVID-19 in another large study done primarily in the United States. THE CANADIAN PRESS/John Woods

AstraZeneca COVID-19 vaccine FAQ: Why do the age recommendations keep changing? Does it cause VIPIT blood clots? Is it effective against variants?

With changing recommendations about AstraZeneca’s COVID-19 vaccine making headlines, many people have questions about its use.
Workers pack syringes at India’s biggest syringe manufacturer. Government support has been key to developing this capacity. Photo by Sajjad Hussain/AFP via Getty Images

South African case study sheds light on how vaccine manufacturing can be developed

African governments, firms and donor agencies should align their efforts to support the local manufacture of vaccines and other health equipment in African countries.
See, no crying or big needles, just a person of colour showing off his plaster. This image does the job without scaring people and demonstrates diversity. from www.shutterstock.com

Pictures of COVID injections can scare the pants off people with needle phobias. Use these instead

Our well-meaning efforts to use images to help demystify the vaccination process or share our pride in getting a COVID vaccine can backfire.
Even though people are ready to venture out and socialize, many are fearful. And some also remember those who lost their lives and want to be careful in their memory. RealPeopleGroup/Getty Images

Anxious about going out into the world? You’re not alone, but there’s help

As more people become vaccinated, many of them are eager to resume their social lives. And yet, many are fearful, and some may not want to return to life as they previously experienced it.
A healthcare worker administers an Oxford/AstraZeneca COVID-19 vaccine to her colleague at Mutuini Hospital in Nairobi. Kenya on March 3, 2021. Photo by Dennis Sigwe/SOPA Images/LightRocket via Getty Images

Kenya’s COVID-19 vaccine rollout has got off to a slow start: the gaps, and how to fix them

Kenya grapples with two major challenges in the vaccination rollout: access to sufficient doses in light of the global shortage; and vaccine hesitancy.
A COVID-19 patient in an ICU unit in a hospital in Capetown, South Africa, in December 2020. A variant emerged in South Africa that has since spread to other parts of the world. Other new variants could emerge elsewhere. Rodger Bosch/AFP via Getty Images

How worried should you be about coronavirus variants? A virologist explains his concerns

As the US vaccinates millions more people each day, the novel coronavirus works to survive. It does this by mutating. So far, several variants are worrisome. A virologist explains what they are.

Les contributeurs les plus fréquents

Plus